TUESDAY, June 25, 2024 (HealthDay News) — A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research suggests. Patients on the strongest dose of ketamine tablets saw significant improvement in their depression compared to a placebo, researchersContinue Reading

MONDAY, June 17, 2024 (HealthDay News) — Genetics can play a role in a person’s odds for Alzheimer’s disease, and new research suggests differences in that risk are based on which parent had the illness. In a study of 4,400 people still “cognitively unimpaired,” there was higher buildup of amyloidContinue Reading